Overview

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

Status:
Terminated

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effects of metformin on functional capacity (pain-free and maximum walking times) in individuals with peripheral artery disease (PAD)-related intermittent claudication.

Phase:

Phase 4

Details

Lead Sponsor:

Baker Heart and Diabetes Institute
Baker IDI Heart and Diabetes Institute

Treatments:

Metformin